The Infusion Rate of Mivacurium and Its Spontaneous Neuromuscular Recovery in Magnesium-Treated Parturients
Authors:
- Eun Kyoung AhnEAEun Kyoung Ahn
- Sun Joon BaiSBSun Joon Bai
- Bum Joon ChoBCBum Joon Cho
- Yang-Sik ShinYSYang-Sik Shin
- 1 March 1998
- journal article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 86 (3) , 523-526
Abstract
Magnesium (Mg) enhances the activity of nondepolarizing neuromuscular blocking drugs.However, no interaction between mivacurium and magnesium has been described. Therefore, we sought to determine the effect of the influence of Mg on the infusion rate of mivacurium and its spontaneous recovery. We studied 24 parturients who had undergone cesarean section under general anesthesia. Those who had been given MgSO (4) for the treatment of preeclampsia were assigned to the Mg group (n = 12), and the other normal parturients were assigned to the NonMg group (n = 12). In both groups, the train-of-four (TOF) response to stimuli of the ulnar nerve was measured at intervals of 15 s. Anesthesia was induced with thiopental and succinylcholine. In both groups, a bolus dose of mivacurium 0.06 mg/kg was administered when the first twitch of TOF (T1) reached 100% after the succinylcholine injection. When the electromyographic response after mivacurium had recovered to approximately 5%-10% of the baseline, a continuous infusion of mivacurium was given to maintain 93%-97% neuromuscular blockade. The plasma concentration of Mg in blood of the Mg group was 4.0 1.0 mEq/L, higher than that (1.4 mEq/L) of the NonMg group (P < 0.01). The infusion rates of mivacurium of Mg and NonMg groups were 1.6 and 5.4 mEq [center dot] kg-1 [center dot] min (-1), respectively. In addition, the recovery indexes of the Mg and NonMg groups were 12.9 and 4.3 min, respectively. We conclude that a smaller dose of mivacurium should be infused to patients receiving Mg. Implications: Magnesium, used as a standard therapy for severe toxemia, may act to enhance muscle relaxants such as mivacurium, a short-acting drug used in general anesthesia. Among women undergoing a cesarean section who were given a magnesium pretreatment, the infusion rate of mivacurium required to obtain relaxation was lower than that among women who did not receive pretreatment. (Anesth Analg 1998;86:523-6)Keywords
This publication has 17 references indexed in Scilit:
- Interaction of magnesium sulphate with vecuronium-induced neuromuscular blockt †British Journal of Anaesthesia, 1995
- The Effect of Plasma Cholinesterase Activity on Mivacurium Infusion RatesAnesthesia & Analgesia, 1995
- PHARMACOKINETICS OF MIVACURIUM N NORMAL PATIENTS AND IN THOSE WITH HEPATIC OR RENAL FAILUREBritish Journal of Anaesthesia, 1992
- Influence of plasma cholinesterase activity on recovery from mivacurium-induced neuromuscular blockade in phenotypically normal patientsActa Anaesthesiologica Scandinavica, 1992
- The Clinical Neuromuscular Pharmacology of Mivacurium Chloride (BW B1090U). A Short-acting Nondepolarizing Ester Neuromuscular Blocking DrugAnesthesiology, 1988
- Neuromuscular Interaction of Magnesium with Succinylcholine-vecuronium Sequence in the Eclamptic ParturientAnesthesiology, 1987
- PHARMACODYNAMICS OF LIDOCAINE IN THE ASPHYXIATED PRETERM FETAL LAMBAnesthesiology, 1986
- Hypermagnesaemia and anaesthetic managementCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1982
- The Interaction between Magnesium and Other Neuromuscular Blocking AgentsAnesthesiology, 1970
- The nature of the neuromuscular block produced by magnesiumThe Journal of Physiology, 1954